Home
About Us|Market Research|Research Report|Report Store|International Trade|Strategic Investment|Contact Us
Report Store
GBI Research Report
Delivery Format: PDF
Published Date: 01-Feb-2010
Pages: 107
Single User Price: $3,500
Site License Price: $7,000
Global Site License: $10,500
File Code: GBIHC022MR
Publisher: GBI Research



Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

Summary Table of contents

Summary

GBI Research, the leading business intelligence provider, has released its latest report, Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting. It provides key data, information and analysis of the major trends and issues affecting the drug discovery market in India and China. The report provides a comprehensive insight into the drug discovery process and the model followed by the companies providing such services. The report also provides a detailed analysis of the factors that are driving the drug discovery market, a key segment of the pharmaceutical and healthcare industry, in India and China. The report talks about the key regulations, especially with respect to intellectual property rights protection, and how these regulations have benefited drug discovery companies in these two nations. The study analyses key partnerships between the local companies in the two countries and their western counterparts and the key trends emerging out of such partnerships. It also provides an insight into the government support initiatives in these countries to encourage the drug discovery research. This research provides a comparative analysis of the two countries and the major differences between India and China when it comes to drug discovery.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Researchs team of industry experts.

Scope

The scope of this report includes:
- Study of major discovery research services including medicinal chemistry, Drug Metabolism and Pharmacokinetics (DMPK), pharmacology and toxicology offered by the Indian and the Chinese drug discovery companies
- Analysis of major therapeutic areas under drug discovery research such as oncology, inflammatory diseases and metabolic diseases
- Study of key Indian and Chinese drug discovery players such as Aurigene, Syngene, WuXi and Shanghai ChemPartner, and their deals/partnerships with western pharma companies
- Analysis of key intellectual property regulations and government support in India and China affecting the drug discovery market
- Analysis of the key drivers that are fueling the growth of the drug discovery market in India and China and future outlook of the drug discovery market in India and China

Reasons to buy

The report will enhance your decision making and will enable you to:
- Optimize your discovery research outsourcing through identification of major service capabilities of the Indian and Chinese drug discovery companies
- Develop market entry and market expansion strategies by identifying the key drivers and restraints in the Indian and Chinese drug discovery market
- Identify the key therapeutic areas in which Indian and Chinese drug discovery companies have major capabilities
- Build a strong presence in the Indian and Chinese drug discovery market through identification of key local players for partnerships and their competencies
- Compare both the countries to identify the geography that could provide maximum capability improvement to your discovery research
- Plan better strategies to protect your intellectual property in these countries
- Enhance and frame better marketing strategies through an understanding of the regulatory environment in these countries


Need more information?
Call us or email us!
Tel:(86)25-85337409
E-mail:zengxian.wu@gmail.com
Home
About Us
Market Research
Research Report
Report Store
International Trade
Strategic Investment
Contact Us
Copyright © 2007-2017 Access China. All rights reserved.   ICP12078369-1   Privacy / Terms and conditions